| Dr Adam Jordan, PHARM D | |
|
210 State St, Bangor, ME 04401-5411 | |
| (207) 992-4458 | |
| (207) 992-4460 |
| Full Name | Dr Adam Jordan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 210 State St, Bangor, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184052706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PR5823 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Jordan, PHARM D 139 Main St, Bangor, ME 04401-6309 Ph: (207) 992-4458 | Dr Adam Jordan, PHARM D 210 State St, Bangor, ME 04401-5411 Ph: (207) 992-4458 |
News Archive
As Americans learn what ObamaCare will mean for quality and access to medical services, "we are witnessing an ever-increasing chorus of Americans - from think tanks to tea partiers to accountants - who are decrying the underhanded tactics" used to get the legislation passed, including the exploitation of the AMA's claim to speak for doctors.
A federal prescription-subsidy program for low-income women on Medicare significantly improved their adherence to hormone therapy to prevent the recurrence of breast cancer after surgery.
Inhibitex, Inc. today announced that the independent data safety monitoring board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with complete 30-day follow-up safety data on the third quartile (75%) of the patients that the Company plans to enroll in the trial. Based upon its review, the DSMB recommended that the trial continue to completion without modification.
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
› Verified 8 days ago
Ashley E Pincins, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-992-4100 Fax: 207-992-2846 | |
Mr. Robert Wayne Cattan Jr., R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 State St, Bangor, ME 04401 Phone: 207-947-8369 Fax: 207-947-0894 | |
Dr. Sarah Mcgillicuddy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 226 Union St, Bangor, ME 04401 Phone: 207-942-0515 | |
Allison White, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Telcom Dr, Bangor, ME 04401 Phone: 802-793-0280 | |
Ms. Erika Lynn Bailey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 417 State St, Suite 130, Bangor, ME 04401 Phone: 207-973-8888 Fax: 207-973-8891 | |
Charles Fichera, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 353 Main St, Bangor, ME 04401 Phone: 207-945-6550 | |
Katharine Freudenberger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 Haskell Rd, Bangor, ME 04401 Phone: 207-945-9723 |